<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-18T15:20:07Z</responseDate><request verb="GetRecord" identifier="oai:uvadoc.uva.es:10324/55602" metadataPrefix="marc">https://uvadoc.uva.es/oai/request</request><GetRecord><record><header><identifier>oai:uvadoc.uva.es:10324/55602</identifier><datestamp>2025-02-13T10:09:32Z</datestamp><setSpec>com_10324_40357</setSpec><setSpec>com_10324_952</setSpec><setSpec>com_10324_894</setSpec><setSpec>col_10324_40358</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dcterms="http://purl.org/dc/terms/" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
<leader>00925njm 22002777a 4500</leader>
<datafield tag="042" ind1=" " ind2=" ">
<subfield code="a">dc</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Katsinas, Nicolaos</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Gehlsen, Uta</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">García Posadas, Laura</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Rodríguez Rojo, Soraya</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Steven, Philipp</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">González García, María Jesús</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="720" ind1=" " ind2=" ">
<subfield code="a">Enriquez De Salamanca Aladro, Amalia</subfield>
<subfield code="e">author</subfield>
</datafield>
<datafield tag="260" ind1=" " ind2=" ">
<subfield code="c">2022</subfield>
</datafield>
<datafield tag="520" ind1=" " ind2=" ">
<subfield code="a">Dry eye (DED) is a prevalent disease with immune-mediated inflammation as the principal pathophysiological etiology. Olive pomace, the major by-product of the olive oil industry, is rich in high-value polyphenols. Their anti-inflammatory and immunomodulatory activities were determined on human CD4+ T cells (hTCD4+) and in a DED animal model. The viability of hTCD4+ cells isolated from peripheral blood and activated with phytohemagglutinin-M was evaluated after treatment for 48 h with an olive pomace extract (OPT3, 0.10–0.40 mg/mL) and its major compound, hydroxytyrosol (25–100 μM). Regarding the DED animal model, 100 μM hydroxytyrosol, 0.20 mg/mL OPT3, or vehicle (borate buffer) were topically administered to 14 days-desiccating stress-exposed (constant airflow/scopolamine administration) C57BL/6 mice. Tear volume, corneal fluorescein staining (CFS), CD4+, and CD8+ T cell count in lymph nodes (flow cytometry), and IP-10 and TNF-α gene expression (qRT-PCR) in the cornea, conjunctiva, and lacrimal glands were evaluated. OPT3 (0.2–0.4 mg/mL) and hydroxytyrosol (100 μM) significantly reduced hTCD4+ proliferation. In mice, both treatments reduced lacrimal gland IP-10 gene expression. OPT3 also decreased CFS, and conjunctival IP-10 and corneal TNF-α gene expression. In lymph nodes, hydroxytyrosol reduced CD3+, OPT3, and CD8+ count. Thus, a high-value application as a promising DED protection was proposed for olive pomace.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">Journal of Clinical Medicine, 2022, Vol. 11, Nº. 16, 17 pp.</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">2077-0383</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">https://uvadoc.uva.es/handle/10324/55602</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">10.3390/jcm11164703</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">1</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">16</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">17</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">Journal of Clinical Medicine</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">11</subfield>
</datafield>
<datafield tag="024" ind2=" " ind1="8">
<subfield code="a">2077-0383</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Ojo - Enfermedades y defectos - Tratamiento</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Síndrome de ojo seco</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Aceite de oliva</subfield>
</datafield>
<datafield ind1=" " ind2=" " tag="653">
<subfield code="a">Aceite de oliva - Análisis</subfield>
</datafield>
<datafield tag="245" ind1="0" ind2="0">
<subfield code="a">Olive pomace phenolic compounds: from an agro-industrial by-product to a promising ocular surface protection for dry eye disease</subfield>
</datafield>
</record></metadata></record></GetRecord></OAI-PMH>